Paul Anthony Mieyal
Direktor/Vorstandsmitglied bei Danube Pharmaceuticals, Inc.
Profil
Paul Anthony Mieyal is currently a Director at Ellipse Technologies, Inc., Danube Pharmaceuticals, Inc., OptiScan Biomedical Corp., Microbiogen Pty Ltd., and Specialty Renal Products, Inc. Previously, he was the Managing Director of Life Sciences Investments at Wexford Capital LP from 2006 to 2020.
He was also a Director at Nephros, Inc. from 2015 to 2020, and at GlobeImmune, Inc., Kirax Corp., Epiphany Biosciences, Inc., Reverse Medical Corp., Nile Therapeutics, Inc., Capricor Therapeutics, Inc., OncoVista Innovative Therapies, Inc., Sophono, Inc., and Vice President at Wechsler & Co., Inc. from 2000 to 2006.
He received his undergraduate degree from Case Western Reserve University and his doctorate from New York Medical College.
Aktive Positionen von Paul Anthony Mieyal
| Unternehmen | Position | Beginn |
|---|---|---|
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Microbiogen Pty Ltd.
 Microbiogen Pty Ltd. BiotechnologyHealth Technology Microbiogen Pty Ltd. develops non-genetically modified yeast. It develop non-genetically modified yeast to generate yeast strains for industrial purposes, which are used for ethanol production, high quality animal feed, baking, yeast extracts, enzymes, antioxidants, and waste stream management amongst others. The company is headquartered in Lane Cove, Australia. | Direktor/Vorstandsmitglied | - |
OptiScan Biomedical Corp.
 OptiScan Biomedical Corp. Medical SpecialtiesHealth Technology OptiScan Biomedical Corp. develops and provides continuous monitoring systems for hospital intensive care units. The company offers OptiScanner 5000, a bedside blood monitoring platform that provides plasma-based, automated monitoring of patients’ glucose levels without the need for calibration, as well as uses a disposable cartridge containing the fluid pathway for sampling, storing, processing, and analyzing blood. The company was founded by James R. Braig and Daniel S. Goldberger in 1994 and is headquartered in Hayward, CA. | Direktor/Vorstandsmitglied | - |
Ellipse Technologies, Inc.
 Ellipse Technologies, Inc. Medical SpecialtiesHealth Technology Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA. | Direktor/Vorstandsmitglied | 01.01.2010 |
Specialty Renal Products, Inc.
 Specialty Renal Products, Inc. Medical SpecialtiesHealth Technology Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Anthony Mieyal
| Unternehmen | Position | Ende |
|---|---|---|
Wexford Capital LP
 Wexford Capital LP Investment ManagersFinance Wexford Capital LP (Wexford) is an independent, SEC-registered investment advisor headquartered in West Palm Beach, Florida with additional office in Stamford, Connecticut. The firm was founded by Charles Davidson, Joseph Jacobs and Robert Holtz in 1994. Wexford provides investment advice to a variety of private pooled investment vehicles over which the firm has discretionary trading authority. | Portfolio Manager-Aktien | 01.12.2020 |
| NEPHROS, INC. | Vorstandsvorsitzender | 15.04.2015 |
| CAPRICOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.11.2013 |
| Nile Therapeutics, Inc. /Old/ | Direktor/Vorstandsmitglied | 01.11.2013 |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Paul Anthony Mieyal
| Case Western Reserve University | Undergraduate Degree |
| New York Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NEPHROS, INC. | Health Technology |
| GLOBEIMMUNE, INC. | Health Technology |
| ONCOVISTA INNOVATIVE THERAPIES, INC. | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Wechsler & Co., Inc.
 Wechsler & Co., Inc. Financial ConglomeratesFinance Wechsler & Co., Inc. operates as an investment company. The company is based in Mount Kisco, NY. | Finance |
Wexford Capital LP
Wexford Capital LP Investment ManagersFinance Wexford Capital LP (Wexford) is an independent, SEC-registered investment advisor headquartered in West Palm Beach, Florida with additional office in Stamford, Connecticut. The firm was founded by Charles Davidson, Joseph Jacobs and Robert Holtz in 1994. Wexford provides investment advice to a variety of private pooled investment vehicles over which the firm has discretionary trading authority. | Finance |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Health Technology |
Ellipse Technologies, Inc.
Ellipse Technologies, Inc. Medical SpecialtiesHealth Technology Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA. | Health Technology |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Health Technology |
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Health Technology |
Reverse Medical Corp.
 Reverse Medical Corp. Electronic Equipment/InstrumentsElectronic Technology Reverse Medical Corp. develops medical devices. The company was founded by Jeffrey Valko and Michael R. Henson in 2007 and is headquartered in Irvine, CA. | Electronic Technology |
OptiScan Biomedical Corp.
OptiScan Biomedical Corp. Medical SpecialtiesHealth Technology OptiScan Biomedical Corp. develops and provides continuous monitoring systems for hospital intensive care units. The company offers OptiScanner 5000, a bedside blood monitoring platform that provides plasma-based, automated monitoring of patients’ glucose levels without the need for calibration, as well as uses a disposable cartridge containing the fluid pathway for sampling, storing, processing, and analyzing blood. The company was founded by James R. Braig and Daniel S. Goldberger in 1994 and is headquartered in Hayward, CA. | Health Technology |
| Nile Therapeutics, Inc. /Old/ | Health Technology |
Microbiogen Pty Ltd.
Microbiogen Pty Ltd. BiotechnologyHealth Technology Microbiogen Pty Ltd. develops non-genetically modified yeast. It develop non-genetically modified yeast to generate yeast strains for industrial purposes, which are used for ethanol production, high quality animal feed, baking, yeast extracts, enzymes, antioxidants, and waste stream management amongst others. The company is headquartered in Lane Cove, Australia. | Health Technology |
Specialty Renal Products, Inc.
Specialty Renal Products, Inc. Medical SpecialtiesHealth Technology Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN. | Health Technology |
Sophono, Inc.
 Sophono, Inc. Medical SpecialtiesHealth Technology Sophono, Inc. manufactures and distributes bone conduction hearing devices. The firm specializes in the development of the Alpha System, an abutment-free, implantable, and bone-anchored hearing system designed for individuals suffering from severe to profound hearing loss or impairment. It focuses on leveraging a surgical procedure with a third- generation sound processor to offer a system for hearing professionals and their patients. The company was founded by Markus Haller in October 2009 and is headquartered in Boulder, CO. | Health Technology |
